The Ministry of Public Health, through its Office of the Permanent Secretary and Vachira...
Southeast Asia Stem Cell Leader Medeze Launches Partial Offer for 10% Stake in SGX-listed Cordlife Group
Offer price of S$0.25 per share is at an attractive premium of 61.3% over...
MEDEZE Surges 4% following Robust Gain in Q1 and Potential Partnership with Singapore’s Cordlife Group
On Tuesday at 2:04 PM (Bangkok time), the share price of MEDEZE Group Public...
MEDEZE Reports Impressive 1Q25 Performance with 27% Profit Growth to THB75 Million
MEDEZE Group Public Company Limited (SET: MEDEZE) has announced robust financial performance for the...
Medeze Invests THB165 Million to Acquire 10% Stake in Asia’s Leading Cord Blood Bank “Cordlife Group”
Medeze Group Public Company Limited (SET: MEDEZE) has announced that its wholly owned subsidiary,...
MEDEZE Expects 30% Growth in 1Q25 with Biotech Investment for New S-Curve
Phiphat Phisanuwongrak, Chief Financial Officer of Medize Group Public Company Limited (SET: MEDEZE), presented...